5th Operationalise: Early Access Programmes Summit Europe

Early Access Programmes have evolved into a critical, but increasingly complex, part of drug development and launch strategy. What was once a reactive pathway is now a strategic lever shaping timelines, evidence generation, and patient access across global markets.

The 5th Operationalise: Early Access Programmes Summit Europe is built for the teams responsible for turning that strategy into execution. As regulatory expectations shift, reimbursement timelines extend, and programmes scale globally, organisations must make more decisions, earlier, and with greater consequence.

This is the only European forum dedicated to the operational reality of early access – bringing together 140+ leaders across Medical Affairs, Access, Regulatory, Clinical Operations, and Supply to share how programmes are being designed, adapted, and delivered in practice.

Whether you are building your first programme, scaling across regions, or managing a global access portfolio, this is your opportunity to benchmark your approach, challenge your assumptions, and leave with the insight needed to make smarter decisions and deliver earlier, sustainable access for patients in 2026 and beyond.

For more information and to register online, please click here.